Define Ventures Appoints Carolyn Magill as Venture Partner

Core Insights - Carolyn Magill, former CEO of Aetion, has joined Define Ventures as a venture partner to drive innovation in the healthcare sector [1][2][3] - Define Ventures is a leading venture capital firm focused on early-stage health tech companies, managing 800 million in assets [4][5] Company Overview - Define Ventures specializes in partnering with companies at seed, series A, and series B stages, emphasizing a high conviction approach [4][5] - The firm has partnered with over two dozen companies, including notable names like Hims & Hers, Unite Us, and Cohere Health [4] Leadership and Expertise - Carolyn Magill brings 25 years of experience in the healthcare ecosystem, having held leadership roles in various organizations, including Aetion and Remedy Partners [2][3] - Her expertise in data and AI applications within the pharmaceutical landscape is expected to be invaluable for Define's partner companies [3] Strategic Vision - Define Ventures aims to shape the future of healthcare by combining a deep understanding of the healthcare ecosystem with a technology-driven mindset [5] - The firm has a track record of delivering over 25 billion in exit value through its investments in category-defining companies [5]